期刊文献+

中医药治疗原发性肝癌的切入点与难点 被引量:15

Breakthrough points and difficulties in traditional Chinese medicine treatment of primary liver cancer
下载PDF
导出
摘要 原发性肝癌是我国常见的恶性肿瘤之一,大多数发现时已经是中晚期,生存期短,预后差。近年来,中医药在原发性肝癌的防治方面展现了其独特的优势,在改善肝癌患者的生存质量、增强免疫力、延长生命等方面有着显著疗效。就原发性肝癌的中西医治疗现状进行了综述,结合临床治疗特点提出中医药治疗的切入点与难点,以期为临床治疗原发性肝癌提供一定的参考。 Primary liver cancer is one of the most common malignant tumors in China,and most patients are in the advanced stage at the time of diagnosis,with a short survival time and poor prognosis.In recent years,traditional Chinese medicine has shown its unique advantages in the prevention and treatment of primary liver cancer and has achieved a marked clinical effect in improving quality of life,enhancing immunity,and prolonging the life of patients with liver cancer.This article reviews the current status of traditional Chinese medicine and Western medicine in the treatment of primary liver cancer and proposes the breakthrough points and difficulties in traditional Chinese medicine treatment based on the features of clinical treatment,in order to provide a reference for the clinical treatment of primary liver cancer.
作者 钊梦媛 张国梁 ZHAO Mengyuan;ZHANG Guoliang(Department of Infectious Diseases, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China)
出处 《临床肝胆病杂志》 CAS 北大核心 2021年第9期2016-2024,共9页 Journal of Clinical Hepatology
基金 国家自然科学基金(81874451)。
关键词 肝肿瘤 中药疗法 中西医结合疗法 Liver Neoplasms Drug Therapy(TCD) TCM WM THERAPY
  • 相关文献

参考文献51

二级参考文献365

共引文献713

同被引文献235

引证文献15

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部